Cargando…
Standards for practical intravenous rapid drug desensitization & delabeling: A WAO committee statement
Drug hypersensitivity reactions (DHRs) to intravenous drugs can be severe and might leave patients and doctors in a difficult position where an essential treatment or intervention has to be suspended. Even if virtually any intravenous medication can potentially trigger a life-threatening DHR, chemot...
Autores principales: | Alvarez-Cuesta, Emilio, Madrigal-Burgaleta, Ricardo, Broyles, Ana D., Cuesta-Herranz, Javier, Guzman-Melendez, Maria Antonieta, Maciag, Michelle C., Phillips, Elizabeth J., Trubiano, Jason A., Wong, Johnson T., Ansotegui, Ignacio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163606/ https://www.ncbi.nlm.nih.gov/pubmed/35694005 http://dx.doi.org/10.1016/j.waojou.2022.100640 |
Ejemplares similares
-
Hypersensitivity reactions to non beta-lactam antimicrobial agents, a statement of the WAO special committee on drug allergy
por: Sánchez-Borges, Mario, et al.
Publicado: (2013) -
Allergen immunotherapy on the way to product-based evaluation—a WAO statement
por: Bachert, Claus, et al.
Publicado: (2015) -
Penicillin allergy delabelling in pregnancy
por: Atkinson, Andrea, et al.
Publicado: (2023) -
WAO consensus on DEfinition of Food Allergy SEverity (DEFASE)()
por: Arasi, Stefania, et al.
Publicado: (2023) -
Improving Antimicrobial Stewardship by Antibiotic Allergy Delabeling: Evaluation of Knowledge, Attitude, and Practices Throughout the Emerging Infections Network
por: Trubiano, Jason A., et al.
Publicado: (2016)